BlackRock Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1M	Buy	318,291 +3,297	+1%	+$10.1K	﹤0.01%	2692
2016 Q3	$1.07M	Buy	314,994 +48,758	+18%	+$135K	﹤0.01%	2619
2016 Q2	$608K	Buy	266,236 +49,312	+23%	+$121K	﹤0.01%	2951
2016 Q1	$545K	Sell	216,924 -12,117	-5%	-$27K	﹤0.01%	2863
2015 Q4	$758K	Buy	229,041 +3,427	+2%	+$10.2K	﹤0.01%	2782
2015 Q3	$546K	Sell	225,614 -7,509	-3%	-$19.4K	﹤0.01%	2994
2015 Q2	$683K	Buy	233,123 +44,420	+24%	+$172K	﹤0.01%	3010
2015 Q1	$757K	Buy	188,703 +1,214	+0.6%	+$4.2K	﹤0.01%	2714
2014 Q4	$564K	Hold	187,489	–	–	﹤0.01%	2945
2014 Q3	$475K	Buy	187,489 +4,616	+3%	+$11.1K	﹤0.01%	3000
2014 Q2	$450K	Buy	182,873 +55,895	+44%	+$126K	﹤0.01%	3093
2014 Q1	$337K	Sell	126,978 -501	-0.4%	-$1.48K	﹤0.01%	3120
2013 Q4	$370K	Sell	127,479 -1,288	-1%	-$3.89K	﹤0.01%	3096
2013 Q3	$395K	Buy	128,767 +10,076	+8%	+$31.9K	﹤0.01%	3028
2013 Q2	$379K	Buy	+118,691	New	+$380K	﹤0.01%	2995